Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Netakimab in Psoriatic Arthritis
NCT03598751Phase 3Completed
- Sponsor
- BIOCAD
- Start
- Jul 2018
- Primary completion
- Jun 2019
- Modality
- Recombinant Proteins and Enzymes, Monoclonal Antibodies
- Countries
- 2
01
Overview
A Phase 3 trial of netakimab in psoriatic arthritis (PsA), sponsored by BIOCAD. Started Jul 2018; status: completed.
02
Drugs
netakimab
03
Conditions
psoriatic arthritis (PsA)
Beyond the preview
Go deeper on NCT03598751.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03598751.